Alexis N. Smith: How Apolipoproteins Influence Platelet Function
Alexis N. Smith, Postdoctoral Fellow at Versiti Inc., shared on LinkedIn about a recent article she and her colleagues co-authored, published in JTH, adding:
”Excited to share that my 1st first‑author publication from my postdoc has been published as a JTH Commentary in the Journal of Thrombosis and Haemostasis.
In this commentary, we discussed a recent paper by W. C. Schrottmaier et al., ‘Elevated levels of apolipoprotein C‑III impair platelet function and reduce thrombosis,’ which highlights an unexpected role for apoC‑III beyond its well‑known links to atherosclerosis.
Their work uncovered that apoC‑III can directly inhibit platelet activation and thrombus formation, providing an important foundation for ongoing research into how apolipoproteins influence platelet function.
Many thanks to my postdoctoral mentor, Ze Zheng, for the support and guidance.”
Title: Atherogenic apolipoprotein C-III may not be as bad as we thought
Authors: Alexis N. Smith, Ziyu Zhang, Ze Zheng
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 27, 2026, 18:19Nabil Tabish: The Paradox of Zero – Investigating Extreme VWF Discordance
-
Jun 27, 2026, 18:19Francesco Favruzzo: Can Mechanical Thrombectomy Be Safely Used in Cervical Artery Dissection?
-
Jun 27, 2026, 18:18Vera Ghali: 2026 ASH–ISTH Recommendations on Pediatric VTE Prevention
-
Jun 27, 2026, 18:17Michiel Coppens: A Hemostasis Laboratory – One of the Cornerstones of Our Hemophilia Mission
-
Jun 27, 2026, 18:16Sthanu Subramanian: Dabigatran and Mechanical Heart Valves
-
Jun 27, 2026, 15:50Muhammet Özbilen: The Skin as an Emerging Regulator of Iron Homeostasis
-
Jun 27, 2026, 15:07Anteneh Berhane: Supporting Healthier Pregnancies Through Early Nutrition
-
Jun 27, 2026, 14:35Mobina Nakhaei: Why Alloantibodies Develop Despite ABO/Rh Matching in Thalassemia
-
Jun 27, 2026, 14:01Abdul Mannan: DOACs in Cancer-Associated VTE – When to Avoid Them, And When LMWH Wins